Loading...
LifeMD Q1 2025 Earnings Report
LifeMD reported strong first-quarter 2025 results, with significant revenue growth and its first-ever quarter of positive GAAP EPS.
Key Takeaways
LifeMD achieved an outstanding first quarter, with total revenues increasing 49% year-over-year to $65.7 million and telehealth revenue up 70%. The company reported its first-ever quarter of positive GAAP net income of $0.6 million, or $0.01 per diluted share, and significantly raised its full-year 2025 guidance.
Total revenues increased 49% year-over-year to $65.7 million.
Telehealth revenue grew 70% year-over-year.
Achieved first-ever quarter of positive GAAP net income of $0.6 million, or $0.01 per diluted share.
Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago period.
Revenue by Segment
Forward Guidance
LifeMD raised its full-year 2025 guidance for both total revenues and adjusted EBITDA, reflecting strong year-to-date performance in telehealth.
Positive Outlook
- Raising full-year 2025 guidance for total revenues to $268 million to $275 million, up from previous guidance of $265 million to $275 million.
- Raising full-year 2025 guidance for adjusted EBITDA to $31 million to $33 million, up from $30 million to $32 million.
- Telehealth revenue for full-year 2025 is expected to be in the range of $208 million to $213 million, up from $205 million to $213 million.
- Telehealth adjusted EBITDA for full-year 2025 is now forecast to exceed $21 million, up from approximately $20 million previously.
- Second quarter 2025 total revenues expected in the range of $65 million to $67 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...